Company News For Dec 27, 2017
Zacks Investment Research | Dec 26, 2017 10:00PM ET
- Shares of Mallinckrodt Public Limited Company (NYSE:MNK) rallied 0.7% after it announced that it had agreed to buy Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) for $1.2 billion which also includes debt
- Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) plummeted 10.7% after it announced that the FDA had increased its review period by 90 days for a biologics license application for the company’s AndexXa product
- Capital One Financial Corporation’s (NYSE:COF) shares tanked 0.6% after the company reduced its amount of authorized share repurchases following Fed’s instructions
- Shares of Fortress Investment Group LLC (NYSE:FIG) declined 0.3% after the company purchased 4% stakes in Theranos — on the verge of bankruptcy, in return of a $100 million loan
Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.